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This review revealed that curcumin treatment can be considered as a supplementary remedy for prevention of oxidative stress, 
inflammation, and immunomodulatory disorders. The literatures support the candidacy of this compound as a possible 
prospective natural drug and raise the possibility of recruiting curcumin in future therapeutic regimens.
Please cite this paper as: Boroumand N, Samarghandian S, Hashemy SI. Immunomodulatory, anti-inflammatory, and 
antioxidant effects of curcumin. J Herbmed Pharmacol. 2018;7(4):211-219. doi: 10.15171/jhp.2018.33.
Turmeric is a widely used spice derived from the rhizomes of Curcuma longa. Having been 
used as a dietary spice, it has drawn scientists’ attention to the possible medicinal benefits of its 
active compounds called curcuminoids which consist of curcumin, demethoxycurcumin and 
bisdemethoxycurcmin. Considering wide range of pharmacological properties that curcumin 
offers, numerous studies have investigated its potency as a therapeutic agent in various 
diseases such as autoimmune, cardiovascular, neoplastic, pulmonary, neurodegenerative and 
metabolic diseases. With regard to its wide array of health benefits and published data on 
the underlying mechanisms of its action, a complex interaction between three main events 
including inflammation, oxidative stress, and immunity, seems to contribute to different 
therapeutic roles of this compound. Hence, this review discusses the current knowledge on 
the anti-inflammatory, antioxidant, and immunomodulatory roles of curcumin with the 
hope of recruiting curcumin as a therapeutic agent in future therapeutic regimen in order 
to enhance the efficacy of the treatment, as well as decreasing the adverse effects of synthetic 
chemical drugs.
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Introduction
Turmeric is a widely used spice derived from the 
rhizomes of Curcuma longa which belongs to the ginger 
family (1). Having been used as a dietary spice, it has 
drawn scientists’ attention to the possible medicinal 
benefits of its active compounds called curcuminoids 
which consist of curcumin, demethoxycurcumin and 
bisdemethoxycurcmin (2). Curcumin is the main active 
component of turmeric and the one which gives turmeric 
its yellow color. It was first introduced by Lampe and 
Milobedzka in 1910 (2,3). Considering a wide range 
of pharmacological properties that curcumin offers, 
numerous studies have investigated its potency as a 
therapeutic agent in various diseases. The conducted 
fundamental researches on cell cultures and animal 
models as well as pilot and clinical trials have provided 
strong evidence for heath promoting activities of this 
compound (4). Accordingly, it has been shown that 
curcumin could play pharmacological roles in various 
disorders such as autoimmune, cardiovascular, neoplastic, 
pulmonary, neurodegenerative and metabolic diseases 
(5). The therapeutic potential of curcumin have been also 
addressed in arthritis, some particular types of cancer, 
inflammatory bowel disease, chronic anterior uveitis, and 
pancreatitis (4). Indeed, several lines of evidence have 
signified antibacterial, antiviral, and antifungal properties 
of this compound (6). With regard to its wide array of 
health benefits and therapeutic roles, a single pathway 
appears unlikely to account for all these activities. With 
this concept, studies moved forward to investigate 
the underlying mechanisms contributing to the heath 
promoting properties of this compound. According to 
the conducted researches, it can be hypothesized that a 
complex interaction between three main events including 
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inflammation, oxidative stress, and immunity is likely to 
contribute to different therapeutic roles of curcumin (7, 
8). Thus, in this review, the current knowledge on the 
anti-inflammatory, antioxidant, and immunomodulatory 
roles of curcumin is discussed with the hope of using 
curcumin as a therapeutic agent in future therapeutic 
regimens in order to not only enhance the efficacy of 
the treatment, but also to decrease the adverse effects of 
synthetic chemical drugs.
Immunomodulatory effects
The immune system has evolved to various specialized 
cells, and soluble molecules that are organized into a 
number of organs and tissues including bone marrow and 
thymus as the central lymphoid organs and lymph nodes, 
spleen as well as mucosal lymphoid tissues, as peripheral 
ones (9).
The immune response conceptually falls into 2 categories: 
innate and adaptive immunity. Innate immunity presents 
a stereotyped rapid response well before the evolution of 
antigen-specific responses provided by adaptive immunity 
(10). It is now apparent that curcumin could greatly affect 
both the innate and adaptive arms of immunity through 
modulating immune cells’ function including neutrophils, 
macrophages, monocytes, natural killer cells (NK cells), 
dendritic cells (DCs), T cells, and B cells (11). This chapter 
provides an overview of the current knowledge on the 
immunomodulatory effects of curcumin on different 
principal effectors of immune system.
The activation, proliferation, and clonal expansion of 
T-lymphocytes occur by their initial encounter with 
antigens presented by antigen-presenting cells (12). The 
depletion or induction of lymphocytes proliferation 
has been frequently used as a criterion in evaluation of 
immunomodulatory effects of therapeutic agents and 
curcumin is no exception (13-16). In this view, several 
studies have investigated the effect of curcumin on 
proliferation of T-cells both ex-vivo and in-vivo. Some 
literatures revealed that following the induction of 
proliferation in T cells by a number of compounds such 
as phytohemagglutinin (PHA), concanavalin A (Con A), 
and phorbol-12-myristate-13-acetate (PMA), curcumin 
treatment could noticeably reduce the proliferation 
(17). However, contradictory data has been published 
regarding the anti-proliferative effect of curcumin on 
the T-lymphocytes, as some studies have signified its 
inductive effects. In this view, Gao et al. conducted a study 
presenting the wide-ranging functions of curcumin at 
different concentrations on murine splenic lymphocytes 
induced by conconavalin A (Con A), IL-2, or alloantigen. 
The results showed a rise in proliferation of Con A-induced 
cells at 6.25 µmol/L concentration of curcumin, while the 
proliferation decreased when 12.5 µmol/L curcumin was 
used. Furthermore, suppressed proliferative responses 
were observed at 25 µmol/L concentration of curcumin. 
With regard to IL-2 induced cells, curcumin showed an 
inhibitory dose dependent manner as the suppressive 
effect of curcumin on proliferation increased along with 
using higher concentration of this compound ranging 
from 6.25 to 25 µmol/L. Meanwhile, the proliferation of 
alloantigen-induced spleen cells suppressed at 30 µmol/L 
curcumin. It is noteworthy that this inhibitory function of 
curcumin was shown to be irreversible (18). These data 
could suggest that the effect of curcumin on proliferation 
rate of T cells depends on both curcumin concentration 
and type of mitogen. However, the majority of published 
data are in favor of its inhibitory effects.
The inhibitory effect of curcumin on other immune 
cells proliferation has also become evident. Studies have 
shown that curcumin has suppressive effects on the 
proliferation of B-cell lymphoma cells. This function of 
curcumin followed a dose- and time-dependent pattern. 
Curcumin applied these effects by down-regulating 
the expression of growth and survival promoting genes 
including c-MYC, BCL-XL and NFκB (19). Coherently, 
a study on B-cell disorders and curcumin concluded 
that early intervention with this compound might delay 
the progression of early hematological malignancies 
including smoldering multiple myeloma, monoclonal 
gammopathy of undetermined significance, and stage 0/1 
chronic lymphocytic leukemia and prolong the survival 
of the patients. Interestingly, they revealed that curcumin 
causes no long-term toxicities even when it is taken over 
5 years (20). In concurrence with this report, Haque et 
al suggested that curcumin treatment could be effective 
in treating B cell autoimmune disease and reducing the 
chance for malignant transformation (21). In addition, 
it has been reported that curcumin could inhibit in vitro 
B-cell immortalization with EBV (22). 
With regard to macrophages, it has been indicated that 
pre-incubation of these cells with 10 μM curcumin 
completely suppressed the generation of superoxide 
anions, nitrite radical, as well as hydrogen peroxide in 
vitro. Furthermore, the rats fed with curcumin in addition 
to their typical diet (containing 8 wt% of coconut oil 
or cod liver oil or olive oil or peanut oil for 8 weeks) 
showed lower levels of reactive oxygen species (ROS) in 
their isolated peritoneal macrophages as compared with 
controls fed with the oil alone. Generally, it is concluded 
that administering curcumin in combination with dietary 
fatty acids reduces ROS generation in macrophages (23). 
In line with this study, Amano et al showed that liposomes 
containing curcumin could suppress the macrophages in 
mice in a selective manner (24). A pathway through which 
curcumin may exert its suppressive effects on macrophages 
has been suggested to be NF‐κB signaling pathway as 
it has been observed that this compound diminishes 
macrophage activation and influenza virus induced-lung 
inflammation by inhibiting NF‐κB pathway (25).
Not only curcumin could affect the proliferation 
and oxidative function of macrophages, but also it 
can influence their polarization via inhibiting TLR4-
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mediated pathway. A study on atheroprotective activity 
of curcumin in human acute monocytic leukemia THP-1 
cells revealed that curcumin exerts aforementioned effects 
through its anti-inflammatory and atheroprotective 
properties (26). To further support the role of curcumin 
in immunomodulation, studies have found that there 
is a correlation between anti-inflammatory effects of 
curcumin and down-regulation of microRNA-155 in 
both LPS-treated macrophages and mice, suggesting that 
curcumin may mediate the suppression of LPS-induced 
inflammatory response through the inhibition of miR-155 
(27).
Curcumin has also been shown to induce apoptosis and 
inhibit proliferation of a number of NK/T-cell lymphoma 
cell lines through mediating some related genes such as 
NFκB, Bcl-xL, and cyclin D1. These results showed that 
curcumin could be used for inducing apoptosis even 
in chemoresistant lymphoma cell lines namely NK-
92 which may become a future therapeutic approach 
(28). Curcumin is also involved in mediating NK cells 
function by increasing nitric oxide (NO) generation in 
NK cells following prolonged treatment and enhancing 
their cytotoxicity (7,29,30). It is noteworthy that the 
combined treatment of curcumin and omega-3 fatty acids 
has shown to increase the NK cell-induced apoptosis of 
pancreatic cancer cells while curcumin alone could inhibit 
interferon-γ production (31), presenting the dual function 
of curcumin which possibly could be highly dependent on 
its in vivo interactions .
Studies further investigated the effect of curcumin on 
DC function. Regarding surface molecules expression, 
curcumin noticeably blocked the expression of CD80, 
CD86, and MHC class II expression. Impaired production 
of some proinflammatory cytokines including IL1β, IL6 
and tumor necrosis factor (TNF)-α was also observed 
in curcumin-treated DCs. The phosphorylation of 
MAPK as well as translocation of NFκB was modulated 
by curcumin (32). These alterations in DC properties 
arises the question that whether curcumin modifies the 
physiological function of DC, for instance its antigen 
capture ability, or not. As further shown by Kim et al, 
interestingly, DC cells treated with curcumin showed high 
efficiency at Ag capturing (32). Furthermore, curcumin 
could affect DC function by arresting its maturation and 
inducing a tolerogenic phenotype through promoting the 
activity of FoxP3+ Tregs (33). The suggested pathways 
through which curcumin has been shown to suppress 
DCs activation in mice with experimental colitis are JAK/
STAT/SOCS signaling pathways (34). Moreover, It is held 
that curcumin could be applied as an immune suppressant 
as it has shown promise in preventing the response of 
human DC cells to immune stimulants (35).
The discussed data from both ex-vivo and in-vivo 
studies provide evidence on the inhibitory effects of 
curcumin on mentioned immune cells’ proliferation and 
suppressing immune responses in some cases which 
could be beneficial in the treatment of autoimmune 
diseases. However, it has been shown that curcumin 
present anti-cancer activities through boosting the 
immune system. It is now apparent that tumor growth and 
survival results from the failure of immune surveillance 
processes in detecting and eliminating the cancer cells. 
Some factors causing this failure have shown to be low 
number of effector T cells (CD4+ and CD8+) as well as 
a shift from Th1-secreted cytokines to Th2 ones, which 
eventually results in diminishing the activity of cytotoxic 
T lymphocytes (CTLs) (36). In this regard, studies have 
shown that curcumin could restore the CD4+ and CD8+ 
cells population, thereby re-establishing the shift towards 
a Th1-secreted cytokines again. It is worth noting that 
the loss of both central and memory T cell was prevented 
by curcumin (37). Coherently, tumor-bearing mice fed 
with curcumin showed a significant decrease in their 
tumor cell number. This reduction followed a dose-
dependent pattern. Indeed, curcumin reinstated the 
decreased immune cell number caused by cancer through 
preventing thymocytes and splenocytes from apoptosis 
(38). Curcumin is further involved in eliminating cancer 
by reducing the T-regulatory cell population, maintaining 
reactive oxygen and nitrogen production by macrophages, 
and NK cell cytotoxic activity (30,39,40).
Despite the well-established anti-cancer role of curcumin, 
the observations regarding immune-suppressive effect 
of curcumin arises the question that how a compound 
could be both anti-cancer and immune-suppressive. The 
discussed findings suggest a dual role for curcumin as both 
inhibitor and inducer of proliferation in immunity cells. 
In fact it seems that curcumin shows distinct responses 
under different circumstances and adopts them according 
to the body condition. For instance in immunity cell 
cancers, namely lymphoma, as discussed earlier, curcumin 
presents inhibitory effects on that particular immune cells 
proliferation while in other type of cancer it increases the 
immune cells’ proliferation to boost immune responses. 
However, further research is required to elucidate the 
exact mechanism or microenvironment condition which 
results in different responses of curcumin.
Anti-inflammatory effects 
Curcumin was found to possess a miraculous power in 
anti-inflammatory processes. Various experimental and 
pharmacologic trials have signified its efficacy as an anti-
inflammatory agent (41). This property of curcumin has 
been shown to be mediated through down-regulating the 
activity of various signaling mediators including down-
regulation of COX-2 activity, mitogen-activated and Janus 
kinases, and inhibiting the generation of TNF-alpha, IL-1, 
-2, -6, -8, -12, and 5′‐Adenosine monophosphate‐activated 
protein kinase (41,42). Recently, remarkable progress has 
been made in our understanding of the inflammatory 
mechanisms targeted by curcumin (5,41,43). This chapter 
addresses the most pivotal mediators affected by this 
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compound within the anti-inflammatory processes.
To begin with, curcumin has been shown to be a potent 
blocker of inflammatory-induced NF-κB activation (44). 
NF-κB is a regulator of most mediators of inflammation 
ranging from chemokines and cytokines to adhesion 
molecules, kinases and enzymes (45). Curcumin 
suppresses NF-κB activation by inhibiting IκBα kinase 
and AKT (46,47). It is also suggested that curcumin targets 
NF-κB via its antioxidant activity. In this view, studies 
have shown that NF-κB DNA-binding activity is induced 
by oxidative stress, thus, antioxidant activity of curcumin 
might result in a depletion in NF-κB DNA-binding activity 
(8,48). Curcumin is also believed to reduce the expression 
of the NF-κB –regulated gene products including IL-1, IL-
6, IL-8, cyclooxygenase-2 (COX-2), 5-LOX, MIP-1α, TNF, 
adhesion molecules, CXCR-4, c-reactive protein (CRP), 
etc (49-52). Likewise, COX-2 is believed to be involved in 
several inflammatory disorders through generating pro-
inflammatory prostaglandins (53,54). COX-2 inhibitors 
have also exhibited potential effects on treating the 
inflammatory diseases (55). There are inconclusive and 
contradictory findings regarding the effects of curcumin 
on COX-2 expression which add ambiguity to explain the 
underlying mechanisms of anti-inflammatory function 
of curcumin. Numerous published studies present that 
curcumin could suppress COX-2 expression (56-58), 
while others believe that it has a inducible effects (59,60). 
However, the authors have shed light on this disparity 
between their findings by explaining that the response 
of malignant and transformed cells may be different 
from those of primary cells to curcumin treatment 
(60). Also, it has been suggested that curcumin with 
concentration higher than 10 μM leads to suppression of 
COX-2, contrariwise, it acts as an inducible factor when 
it is imposed in lower doses (58,60,61). Furthermore, 
regarding the exact target of curcumin in inhibiting the 
expression of COX-2, it is shown that curcumin treatment 
could inhibit the expression of COX-2 at both mRNA and 
protein levels (60,62).
Besides COX-2, inducible nitric oxide synthase (iNOS) is 
also known to be implicated in inflammatory responses 
(63). Indeed, iNOS is reported to be another target for 
curcumin (64). iNOS results in NO generation, a well-
known pro-inflammatory mediator (65). Moreover, 
published studies have demonstrated that iNOS applies 
its anti-inflammatory function through the regulation of 
COX-2 and, thus, generating prostaglandins (66). Studies 
have shown that curcumin acts as an anti-inflammatory 
agent through inhibiting the NO generation as well 
as iNOS expression at both protein and mRNA levels 
(67,68). Moreover, it has been shown that curcumin might 
downregulate the iNOS gene via suppression of c-Jun/
AP-1 activation (68).
The other target of curcumin in reducing inflammation 
is believed to be TNF. TNF has shown to exert pro-
inflammatory effects through TNF receptor 2 (69). It has 
been suggested that curcumin could modulate the TNF-α-
associated inflammatory pathways (70). Some publications 
have shown that curcumin inhibits TNF production, but 
still, the exact underlying signaling are unclear (51,70) . 
Nevertheless, there are several possibilities regarding the 
TNF-α regulation by curcumin as presented by both in 
vitro and animal studies. For instance, it has been reported 
that curcumin could negatively regulate pro-inflammatory 
transcription factors including NF-kB, STAT proteins, 
and activator protein-1, thereby modulating TNF-α 
production (71). The interruption of signaling between 
TNF-α and its receptor by curcumin direct binding has 
also been suggested as another mechanism through which 
curcumin could suppress the inflammation induced by 
this cytokine (72).
In accordance with the investigations on inflammatory 
signaling mediators which curcumin targets, experimental 
studies have further proved the anti-inflammatory 
activity of this compound. In this aspect, animal studies 
on the effect of curcumin on inflammation have shown 
that administering curcumin could also inhibit in-vivo 
inflammation. In this regard, a study conducted on rat 
model of streptococcal cell wall-induced rheumatoid 
arthritis showed that injection of an extract containing 
curcuminoids prior to induction of arthritis prevented 
joint inflammation, remarkably (73). Curcumin also 
reduced inflammation in rat models of pancreatitis through 
suppressing NF-κB and AP-1 as well as decreasing TNF-a, 
IL-6, and iNOS in the pancreas, thereby an improvement 
in disease severity was observed (74).
Taken together, the discussed publications provide strong 
evidence for the anti-inflammatory properties of curcumin 
which might become as a simpler answer, in comparison 
with current therapies, to various inflammatory diseases.
Antioxidant effects 
Curcumin is known for its antioxidant and radical 
scavenging properties. The unique chemical structure 
of this compound including its carbon–carbon double 
bonds, B-diketo group, and phenyl rings with hydroxyl 
and methoxy substituents has been proven to attribute to 
its antioxidant activity (8,75). Scientists believe that the 
superb antioxidant features of curcumin are mainly due to 
its H-atom donation from the phenolic group (76).
In recent years, there has been a particular interest in 
investigating scavenging properties of curcumin. Studies 
have shown that curcumin could scavenge free radicals 
efficiently (76,77). Besides, evidence demonstrated 
that curcumin is mainly involved in scavenging of 
these radicals in peroxidation processes. Therefore, 
possessing a great potency to inhibit lipid peroxidation, 
curcumin could protect cell membrane from oxidative 
damage by positioning itself within the cell membrane 
(8,75). In this scenario, studies indicated that curcumin 
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inhibits peroxidation mainly through its iron binding 
capacity (76). Curcumin also is considered as a potential 
antioxidant against hydrogen peroxide and superoxide 
radical generation (76).
The antioxidant properties of curcumin set up essential 
protective tasks for this compound specifically in 
reproductive system. For instance, it is well-understood 
that an appropriate balance between oxidant and 
antioxidant is a crucial factor for efficient performance 
of human reproductive system (78). Studies have shown 
that curcumin could protect structural integrity and 
functional activity of the spermatozoa particularly when 
oxidative damage to the germ cells is elevated. It could be 
explained by its phenol group which prevents oxidative 
cellular damage (79,80). In accordance with this data 
earlier studies have shown that curcumin could have 
ameliorative effects on the both antioxidant status and 
activity of reproductive cells and tissues in mice treated 
with metronidazole (81). Considering more studies 
in this aspect, studies have reported that the balance 
between oxidant and antioxidant is often altered following 
cryopreservation of semen. Curcumin has been shown to 
preserve this balance by its antioxidant capacity (82). The 
stabilization of the total antioxidant equilibrium mediated 
by curcumin also results in protection of DNA integrity 
and viability in rat spermatozoa (82). Furthermore, it has 
been shown that treatment of spermatozoa with curcumin 
results in preservation of its motion, and preserves its 
mitochondrial as well as antioxidant characteristics, 
which are characterized by elevated superoxide dismutase 
(SOD), glutathione peroxidase (GPx), catalase (CAT) 
and glutathione (GSH) activities following curcumin 
treatment (83).
Curcumin was also shown to have potential effects on 
inhibiting oxidative damages caused by chronic stress in 
vital organs including brain, liver and kidney. It has been 
proven that curcumin plays this role through maintaining 
the SOD and GPx activity as well as reversing the stress-
induced inhibition of CAT. These functions of curcumin 
may eventually result in a reduction in lipid peroxidation 
and, thus, ameliorate the detrimental effect of chronic 
stress on tissues (84).
Moreover, since oxidative stress is implicated in most of the 
neurodegenerative diseases, studies have investigated the 
possible protective effect of curcumin as an antioxidant, 
on astrocytes. In this regard, Daverey et al showed that 
curcumin not only inhibits the oxidative stress and its 
following adverse effects, but also protects astrocytes. 
Curcumin exhibited its antioxidant activity through 
ameliorating astrogliosis markers (GFAP and vimentin) 
and suppressing upregulation of Prdx6 induced by 
oxidative stress (85). In addition, treatment with curcumin 
results in recovery of the damaged mitochondria caused by 
oxidative stress (85). Furthermore, Wu et al demonstrated 
that curcumin treatment elevated both protein expression 
and enzyme activity of thioredoxin in rat cerebral cortical 
neurons, thus preserving them against cell injury (86). 
The antioxidant activity of this compound can be further 
confirmed by the study conducted by Suryanarayana et al 
who investigated the effect of curcumin administration 
on streptozotocin-induced hyperglycemic rat, as they 
showed elevated protein carbonyls, lipid peroxidation and 
altered activities of enzymatic antioxidant. Subsequently, 
administering curcumin and turmeric inhibits oxidative 
stress and reversed the altered balance (87).
It is worth noting that as discussed in the former section 
curcumin treatment suppressed the generation of 
superoxide anions, nitrite radical, as well as hydrogen 
peroxide in macrophages in vitro. This fact could be 
due to the antioxidant effects of curcumin. However, as 
macrophages use these oxidative mediators to combat 
the invader we could be facing a paradigm shift in how 
antioxidant activity of this compound should be viewed 
in inflammatory conditions particularly in terms of 
macrophages function. Beside this fact, in contrast to the 
traditional view of oxidative mediators, as a cause of tissue 
destruction and mediating inflammation, scientists have 
suggested that ROS are implicated in diminishing the 
inflammatory response. ROS also have been reported to 
be beneficial in autoimmune conditions (88). However, 
these hypotheses demand further support and are yet 
to be adequately understood since there are few studies 
discussing these issues, thus, it remains inconclusive.
Conclusion
In view of the discussed findings, future therapeutic 
approaches could rely on the ability of curcumin 
to prevent the oxidative stress, inflammation and 
immunomodulatory disorders. The literatures support 
the candidacy of this compound as a possible prospective 
natural drug and raise the possibility of recruiting 
curcumin in future therapeutic regimens. However, 
Additional studies and further investigations are needed 
to provide a better comprehension of the role of curcumin 
in prevention as well as treatment of the aforementioned 
disorders for better management of patients affected 
by these conditions. Moreover, the exact role of this 
compound as an antioxidant, anti-inflammatory and 
immunomodulatory agent should be well distinguished.
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